Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1980 Nov;66(5):934–940. doi: 10.1172/JCI109961

Identification of a congenital dysthrombin, thrombin Quick.

R A Henriksen, W G Owen, M E Nesheim, K G Mann
PMCID: PMC371528  PMID: 6776145

Abstract

A dysprothrombin designated prothrombin Quick, is isolated from the plasma of an individual with < 2% of normal functional prothrombin activity and 34% of the normal prothrombin level by immunologic assay. With Factor Xa or taipan snake venom as activators, a fragmentation pattern identical to that of normal prothrombin is observed on gel electrophoresis in dodecylsulfate. This evidence combined with the observed barium citrate adsorption of prothrombin Quick and the low activity suggests that the defect in prothrombin Quick is in the thrombin portion of the molecule. Thrombin Quick is isolated and comigrates with thrombin on dodecyl sulfate gel electrophoresis, either reduced or nonreduced. The activity of thrombin Quick on several biological substrates of thrombin is investigated. Relative to normal thrombin, thrombin Quick is 1/200 as active on fibrinogen and 1/20-1/50 as effective in activating Factors V and VIII and aggregating platelets. A complex with antithrombin III is detected by dodecyl sulfate gel electrophoresis. Further investigation with the active site titrant, dansylanginine-N-(3-ethyl-1,5-pentanediyl)amide showed that the thrombin Quick preparation has the same affinity for the titrant as thrombin, but apparently only 40% active sites per mole protein are titrable.

Full text

PDF
934

Images in this article

935Image
on p.935
936Image
on p.936

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aronson D. L. Chromatographic differentiation of human prothrombins. Thromb Diath Haemorrh. 1966 Dec 1;16(3):491–496. [PubMed] [Google Scholar]
  2. BORN G. V., CROSS M. J. THE AGGREGATION OF BLOOD PLATELETS. J Physiol. 1963 Aug;168:178–195. doi: 10.1113/jphysiol.1963.sp007185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Davie E. W., Fujikawa K., Kurachi K., Kisiel W. The role of serine proteases in the blood coagulation cascade. Adv Enzymol Relat Areas Mol Biol. 1979;48:277–318. doi: 10.1002/9780470122938.ch6. [DOI] [PubMed] [Google Scholar]
  4. Downing M. R., Butkowski R. J., Clark M. M., Mann K. G. Human prothrombin activation. J Biol Chem. 1975 Dec 10;250(23):8897–8906. [PubMed] [Google Scholar]
  5. Girolami A., Bareggi G., Brunetti A., Sticchi A. Prothrombin padua: a "new" congenital dysprothrombinemia. J Lab Clin Med. 1974 Nov;84(5):654–666. [PubMed] [Google Scholar]
  6. Girolami A., Coccheri S., Palareti G., Poggi M., Burul A., Cappellato G. Prothrombin Molise: a "new" congenital dysprothrombinemia, double heterozygosis with an abnormal prothrombin and "true" prothrombin deficiency. Blood. 1978 Jul;52(1):115–125. [PubMed] [Google Scholar]
  7. Gitel S. N., Owen W. G., Esmon C. T., Jackson C. M. A polypeptide region of bovine prothrombin specific for binding to phospholipids. Proc Natl Acad Sci U S A. 1973 May;70(5):1344–1348. doi: 10.1073/pnas.70.5.1344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HARDISTY R. M., MACPHERSON J. C. A one-stage factor VIII (antihaemophilic globulin) assay and its use on venous and capillary plasma. Thromb Diath Haemorrh. 1962 May 15;7:215–228. [PubMed] [Google Scholar]
  9. Josso F., Monasterio de Sanchez J., Lavergne J. M., Menache D., Soulier J. P. Congenital abnormality of the prothrombin molecule (factor II) in four siblings: prothrombin Barcelona. Blood. 1971 Jul;38(1):9–16. [PubMed] [Google Scholar]
  10. Kahn M. J., Govaerts A. Prothrombin Brussels, a new congenital defective protein. Thromb Res. 1974 Aug;5(2):141–156. doi: 10.1016/0049-3848(74)90064-4. [DOI] [PubMed] [Google Scholar]
  11. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  12. Lages B., Scrutton M. C., Holmsen H. Studies on gel-filtered human platelets: isolation and characterization in a medium containing no added Ca2+, Mg2+, or K+. J Lab Clin Med. 1975 May;85(5):811–825. [PubMed] [Google Scholar]
  13. Lundblad R. L. A rapid method for the purification of bovine thrombin and the inhibition of the purified enzyme wtih phenylmethylsulfonyl fluoride. Biochemistry. 1971 Jun 22;10(13):2501–2506. doi: 10.1021/bi00789a012. [DOI] [PubMed] [Google Scholar]
  14. Nesheim M. E., Myrmel K. H., Hibbard L., Mann K. G. Isolation and characterization of single chain bovine factor V. J Biol Chem. 1979 Jan 25;254(2):508–517. [PubMed] [Google Scholar]
  15. Nesheim M. E., Prendergast F. G., Mann K. G. Interactions of a fluorescent active-site-directed inhibitor of thrombin: dansylarginine N-(3-ethyl-1,5-pentanediyl)amide. Biochemistry. 1979 Mar 20;18(6):996–1003. doi: 10.1021/bi00573a010. [DOI] [PubMed] [Google Scholar]
  16. Owen C. A., Jr, Henriksen R. A., McDuffie F. C., Mann K. G. Prothrombin Quick. A newly identified dysprothrombinemia. Mayo Clin Proc. 1978 Jan;53(1):29–33. [PubMed] [Google Scholar]
  17. Owen W. G. Evidence for the formation of an ester between thrombin and heparin cofactor. Biochim Biophys Acta. 1975 Oct 20;405(2):380–387. doi: 10.1016/0005-2795(75)90103-8. [DOI] [PubMed] [Google Scholar]
  18. QUICK A. J., PISCIOTTA A. V., HUSSEY C. V. Congenital hypoprothrombinemic states. AMA Arch Intern Med. 1955 Jan;95(1):2–14. doi: 10.1001/archinte.1955.00250070018002. [DOI] [PubMed] [Google Scholar]
  19. Shapiro S. S., Martinez J., Holburn R. R. Congenital dysprothrombinemia: an inherited structural disorder of human prothrombin. J Clin Invest. 1969 Dec;48(12):2251–2259. doi: 10.1172/JCI106191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Straughn W., 3rd, Wagner R. H. A simple method for preparing fibrinogen. Thromb Diath Haemorrh. 1966 Jul 31;16(1):198–206. [PubMed] [Google Scholar]
  21. Tangen O., Berman H. J. Gel filtration of blood platelets: a methodological report. Adv Exp Med Biol. 1972;34:235–243. doi: 10.1007/978-1-4684-3231-2_13. [DOI] [PubMed] [Google Scholar]
  22. WAGNER B. H., MCLESTER W. D., SMITH M., BRINKHOUS K. M. PURIFICATION OF ANTIHEMOPHILIC FACTOR (FACTOR VIII) BY AMINO ACID PRECIPITATION. Thromb Diath Haemorrh. 1964 Apr 15;11:64–74. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES